Company · Private

Mitrix Bio

Develops transplantation of lab-grown, autologous mitochondria as a therapy for age-related mitochondrial dysfunction.

Listing

Private

Ticker

—

Headquarters

—

Founded

—

Technology

Mitochondrial transplantation

Longevity thesis

Rather than repairing mitochondria in place, supplying cells with externally grown healthy mitochondria could bypass accumulated organelle damage.

Programmes

Mitochondrial transplantation programmePreclinical
Age-related mitochondrial dysfunction

Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.